These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3102063)

  • 1. I-Ad antigen expression of pyran copolymer-induced peritoneal cells in tumor vaccine-primed mice and its association with the host antitumor response.
    Oh-hashi F; Kataoka T; Taniyama T
    Cancer Immunol Immunother; 1987; 24(1):57-63. PubMed ID: 3102063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-cytotoxic activity of pyran copolymer-induced macrophages associated with potentiation of tumour vaccine in recipient mice.
    Kataoka T; Oh-hashi F
    Cancer Immunol Immunother; 1985; 20(1):69-74. PubMed ID: 2998590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitomycin C-augmented production of I-A antigen-positive macrophages in tumor vaccine-primed mice.
    Kataoka T; Yamamoto T; Honjo K; Murayama T
    Jpn J Cancer Res; 1986 Mar; 77(3):305-11. PubMed ID: 3009373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific potentiation of L1210 vaccine by pyran copolymer.
    Mohr SJ; Chirigos MA; Smith GT; Fuhrman FS
    Cancer Res; 1976 Jun; 36(6):2035-9. PubMed ID: 1268855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical and biological adjuvants capable of potentiating tumor cell vaccine.
    Chirigos MA; Stylos WA; Schultz RM; Fullen JR
    Cancer Res; 1978 Apr; 38(4):1085-91. PubMed ID: 416906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
    Rao VS; Mitchell MS
    J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of mouse macrophages by pyran copolymer and role in augmentation of natural killer activity.
    Puccetti P; Santoni A; Riccardi C; Holden HT; Herberman RB
    Int J Cancer; 1979 Dec; 24(6):819-25. PubMed ID: 232496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO; Johnson WJ; Marino PA; Dean JH
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents.
    Kataoka T; Oh-hashi F; Sakurai Y; Gomi K
    Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice.
    Okura A; Arakawa H; Yoshinari T; Naito K; Ishizuka M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1986 Apr; 39(4):575-80. PubMed ID: 3458691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine adjuvant effects, and immune response, to synthetic polymers MVE and poly ICLC.
    Chirigos MA; Welker R; Schlick E; Saito T; Ruffmann R
    Prog Clin Biol Res; 1984; 161():467-79. PubMed ID: 6483899
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct activation in vitro of mouse peritoneal macrophages by pyran copolymer (NSC 46015).
    Schultz RM; Papamatheakis JD; Chirigos MA
    Cell Immunol; 1977 Mar; 29(2):403-9. PubMed ID: 862029
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular and serum involvement in protection against Friend leukemia virus.
    Schuller GB; Morahan PS
    Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine.
    Kataoka T; Oh-hashi F
    Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elimination of suppressor macrophages in tumor-bearing mice by 6-mercaptopurine and its therapeutic contribution].
    Kataoka T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):701-5. PubMed ID: 3963841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of activity of mouse natural killer (NK) cells by activated macrophages from mice treated with pyran copolymer.
    Santoni A; Riccardi C; Barlozzari T; Herberman RB
    Int J Cancer; 1980 Dec; 26(6):837-43. PubMed ID: 6452418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
    Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
    Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OK-432-mediated augmentation of antitumor immunity and generation of cytotoxic T lymphocytes.
    Ujiie T
    Jpn J Exp Med; 1987 Apr; 57(2):103-15. PubMed ID: 3499533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadjuvant activity of pyran copolymer. I. Evidence for direct stimulation of T-lymphocytes and macrophages.
    Baird LG; Kaplan AM
    Cell Immunol; 1975 Dec; 20(2):167-76. PubMed ID: 1106874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.